These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 23607096)

  • 21. Mechanisms of islet amyloidosis toxicity in type 2 diabetes.
    Abedini A; Schmidt AM
    FEBS Lett; 2013 Apr; 587(8):1119-27. PubMed ID: 23337872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.
    Bharadwaj P; Wijesekara N; Liyanapathirana M; Newsholme P; Ittner L; Fraser P; Verdile G
    J Alzheimers Dis; 2017; 59(2):421-432. PubMed ID: 28269785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Cholesterol and Phospholipids in Amylin Misfolding, Aggregation and Etiology of Islet Amyloidosis.
    Singh S; Trikha S; Bhowmick DC; Sarkar AA; Jeremic AM
    Adv Exp Med Biol; 2015; 855():95-116. PubMed ID: 26149927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Amylin under examination. Fibrillation - cytotoxic pancreatic polypeptide aggregation].
    Marszałek M
    Postepy Hig Med Dosw (Online); 2015 Mar; 69():309-19. PubMed ID: 25748622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clustering and internalization of toxic amylin oligomers in pancreatic cells require plasma membrane cholesterol.
    Trikha S; Jeremic AM
    J Biol Chem; 2011 Oct; 286(41):36086-36097. PubMed ID: 21865171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In silico cross seeding of Aβ and amylin fibril-like oligomers.
    Berhanu WM; Yaşar F; Hansmann UH
    ACS Chem Neurosci; 2013 Nov; 4(11):1488-500. PubMed ID: 24007594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The human islet amyloid polypeptide in protein misfolding disorders: Mechanisms of aggregation and interaction with biomembranes.
    Saghir AE; Farrugia G; Vassallo N
    Chem Phys Lipids; 2021 Jan; 234():105010. PubMed ID: 33227292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRICHOS domain of Bri2 inhibits islet amyloid polypeptide (IAPP) fibril formation and toxicity in human beta cells.
    Oskarsson ME; Hermansson E; Wang Y; Welsh N; Presto J; Johansson J; Westermark GT
    Proc Natl Acad Sci U S A; 2018 Mar; 115(12):E2752-E2761. PubMed ID: 29507232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The amylin peptide implicated in type 2 diabetes stimulates copper-mediated carbonyl group and ascorbate radical formation.
    Masad A; Tabner BJ; Mayes J; Allsop D
    Free Radic Biol Med; 2011 Aug; 51(4):869-75. PubMed ID: 21683137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloidogenicity, Cytotoxicity, and Receptor Activity of Bovine Amylin: Implications for Xenobiotic Transplantation and the Design of Nontoxic Amylin Variants.
    Akter R; Bower RL; Abedini A; Schmidt AM; Hay DL; Raleigh DP
    ACS Chem Biol; 2018 Sep; 13(9):2747-2757. PubMed ID: 30086232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The S20G substitution in hIAPP is more amyloidogenic and cytotoxic than wild-type hIAPP in mouse islets.
    Meier DT; Entrup L; Templin AT; Hogan MF; Mellati M; Zraika S; Hull RL; Kahn SE
    Diabetologia; 2016 Oct; 59(10):2166-71. PubMed ID: 27393137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amylin Pharmacology in Alzheimer's Disease Pathogenesis and Treatment.
    Corrigan RR; Piontkivska H; Casadesus G
    Curr Neuropharmacol; 2022; 20(10):1894-1907. PubMed ID: 34852745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent insights in islet amyloid polypeptide-induced membrane disruption and its role in beta-cell death in type 2 diabetes mellitus.
    Khemtémourian L; Killian JA; Höppener JW; Engel MF
    Exp Diabetes Res; 2008; 2008():421287. PubMed ID: 18483616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. β-Cell failure in type 2 diabetes: a case of asking too much of too few?
    Costes S; Langen R; Gurlo T; Matveyenko AV; Butler PC
    Diabetes; 2013 Feb; 62(2):327-35. PubMed ID: 23349537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Structure, Membrane Interactions, and Toxicity of the Islet Amyloid Polypeptide in Type 2 Diabetes Mellitus.
    Caillon L; Hoffmann AR; Botz A; Khemtemourian L
    J Diabetes Res; 2016; 2016():5639875. PubMed ID: 26636105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperamylinemia as a risk factor for accelerated cognitive decline in diabetes.
    Ly H; Despa F
    Expert Rev Proteomics; 2015; 12(6):575-7. PubMed ID: 26503000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Vitro Studies of Membrane Permeability Induced by Amyloidogenic Polypeptides Using Large Unilamellar Vesicles.
    Cao P; Raleigh DP
    Methods Mol Biol; 2016; 1345():283-90. PubMed ID: 26453219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional proteasome complex is required for turnover of islet amyloid polypeptide in pancreatic β-cells.
    Chatterjee Bhowmick D; Jeremic A
    J Biol Chem; 2018 Sep; 293(37):14210-14223. PubMed ID: 30012886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix metalloproteinase-9 reduces islet amyloid formation by degrading islet amyloid polypeptide.
    Aston-Mourney K; Zraika S; Udayasankar J; Subramanian SL; Green PS; Kahn SE; Hull RL
    J Biol Chem; 2013 Feb; 288(5):3553-9. PubMed ID: 23229548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pathogenic mechanism of diabetes varies with the degree of overexpression and oligomerization of human amylin in the pancreatic islet β cells.
    Zhang S; Liu H; Chuang CL; Li X; Au M; Zhang L; Phillips AR; Scott DW; Cooper GJ
    FASEB J; 2014 Dec; 28(12):5083-96. PubMed ID: 25138158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.